Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C7WG
|
|||
Former ID |
DNC010197
|
|||
Drug Name |
3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H11N3O3S
|
|||
Canonical SMILES |
C1=CC(=CC(=C1)S(=O)(=O)N)N=NC2=CC=C(C=C2)O
|
|||
InChI |
1S/C12H11N3O3S/c13-19(17,18)12-3-1-2-10(8-12)15-14-9-4-6-11(16)7-5-9/h1-8,16H,(H2,13,17,18)
|
|||
InChIKey |
HJVKSSWMWPZDOV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the... Bioorg Med Chem. 2009 Oct 15;17(20):7093-9. | |||
REF 2 | Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesul... Bioorg Med Chem Lett. 2009 Sep 1;19(17):4929-32. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.